Meetings and publications | |
>> VHPB meetings |
Viral Hepatitis Prevention Board
Sofia, Bulgaria, March 24-25, 2011
Burden and Prevention of Viral Hepatitis in Bulgaria
Thursday, March 24, 2011
Session 1 Opening and objectives
Chair: Angel Kunchev, Mira Kojouharova
09.00 - 09.30
09.30 10.00
Impact of the hepatitis resolution adopted by the World Health Assembly (WHA 63.18) 236 Kb (.pdf)
Steven Wiersma
Session 2 The Health Care system in Bulgaria
Chair: Angela Dominguez , Nadezhda Vladimirova
10.30 10.50
Organisation and funding of the health system in Bulgaria 1.6 Mb (.pdf)
Tatiana Ivanova
10.50 11.10
National immunisation program 657Kb (.pdf)
Radosveta Filipova
11.10 11.30
Overview of communicable disease surveillance system in Bulgaria 872Kb (.pdf)
Mira Kojouharova
11.30 11.45
Healthcare Policy for vulnerable groups, especially Roma in Bulgaria 783 Kb (.pdf)
Rossitsa Ivanova
11.45 12.00
Concept of health mediators history, job description and mediators activities 2.4 Mb (.pdf)
Ivailo Tarnev
12.00 12.20 Discussion
12.20 13.40 Lunch
Session 3 Epidemiology of viral hepatitis in Bulgaria
Chair: Wolfgang Jilg , Nina Gatcheva
13.40 14.00
Epidemiology of viral hepatitis in Bulgaria. 519 Kb (.pdf)
Nadezhda Vladimirova,
14.00 14.20
Molecular epidemiology of HBV and HCV. 1.9 Mb (.pdf)
Pavel Teoharov
14.20 14.40
Phylogenetic reconstruction of two large HAV outbreaks occurring simultaneously in different regions in Bulgaria 1.7 Mb (.pdf)
Anton Andonov
14.40 15.00
Seroepidemiological study on HBV and HCV prevalence in Bulgaria 1.7 Mb (.pdf)
Ani Kevorkian
15.00 15.20
Viral hepatitis and surveillance in Blood bank in Bulgaria. 1.5 Mb (.pdf)
Svetla Bakalova
15.20 15.30 Discussion
15.30 15.50 Lunch
Chair: Daniel Shouval , Tatiana Tcherveniakova
15.50 16.10
IDU risk group and viral hepatitis 2.8 Mb (.pdf)
Violeta Bogdanova
16.10 16.30
Sero-epidemiology of viral hepatitis in haemodialysis and control measures 461 Kb (.pdf)
Evgueniy Vazelov, V. Mushekov
16.30 16.50
Health care-associated viral hepatitis C. 1 Mb (.pdf)
Rossitza Vatcheva-Dobrevska
16.50 17.10
Quality of life of patients with HBV infection case study with SF-36. 453 Kb (.pdf)
Alexandra Tzenova-Savova
17.10 17.30
Viral hepatitis- The patients impact in Bulgaria. (Hepasist). 1.2 Mb (.pdf)
Stanimir Hasurdjiev
17.30 17.45 Discussion
17.45 15.05 End of the Day
Friday, March 25, 2011
Session 4 Prevention and Control of viral hepatitis in Bulgaria
Chair: Mark Kane , Anton Andonov
09.00 09.20
Clinical aspects of viral hepatitis.3.9 Mb (.pdf)
Tatiana Tcherveniakova
09.20 09.40
Treatment and laboratory monitoring of chronic hepatitis patients in Bulgaria. 1.8 MB (pdf)
Krassimir Antonov
09.40 10.00
Control of viral hepatitis in haemodialysis.
Stefan Krivoshiev
10.00 10.20
Hepatitis A in city of Plovdiv in 2006 outbreak investigation and control measures 1.9 Mb (.pdf)
Angel Kunchev, Monika Troyancheva
10.20 10.30 Discussion
10.30 10.50 Coffee break
Session 5 Evaluation of the Prevention and Control of Viral Hepatitis in Bulgaria
Chair:Liudmilla Mosina , Krassimir Antonov
10.50 11.10
National Hepatitis B vaccination programme: cost-benefit assessment of introduction of universal HBV vaccination of newborns in Bulgaria 454Kb (.pdf)
Anna Kurchatova
11.10 11.30
Epidemiological effectiveness of the universal newborn HBV vaccination: 20 years after. 89 Kb (.pdf)
Mira Kojouharova
11.30 11.50
Economic analysis of the universal HBV vaccination 20 years after introduction. 826 Kb (.pdf)
Guenka Petrova
11.50 12.10
Protection of medical staff through hepatitis B vaccination: serological and epidemiological data from hospitals in Bulgaria 1.4 Mb (.pdf)
Nina Gatcheva
12.10 12.30
Our experience in prevention by selective immunization against viral hepatitis A and B of the staff of Military Medical Academy Bulgaria 1.8 Mb (.pdf)
Andrey Galev
12.30 12.45 Discussion
12.45 14.10 Lunch
Session 6 Conclusions of the meeting
Chair: Johannes Hallauer , Mira Kojouharova
14.15 15.15
Presentation of the VHPB meeting conclusions 64 Kb(.pdf)
David FitzSimons
15.15 Close of the meeting